Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (91-100 of 7,104) with videos related to

Pageof 711
Sort By:
Cancer Science|November 20, 2010
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cellsYusuke Tomita, Michiko Harao, Satoru Senju, et al.
Cancer Science|March 16, 2011
A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathwayMorihiko Sagawa, Takatsune Shimizu, Naoshi Fukushima, et al.
Cancer Science|March 16, 2011
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancerSatoshi Matsusaka, Mitsukuni Suenaga, Yuji Mishima, et al.
Cancer Science|March 16, 2011
Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapyYasufumi Sato
Cancer Science|March 5, 2011
Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patientsHidekazu Kameshima, Tetsuhiro Tsuruma, Toshihiko Torigoe, et al.
Cancer Science|March 5, 2011
Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancerMakoto Osanai, Gang-Hong Lee
Cancer Science|March 30, 2011
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppressionYong-Mei Yang, A-Lei Feng, Cheng-Jun Zhou, et al.
Cancer Science|March 30, 2011
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivoShu Tian, Haitian Quan, Chengying Xie, et al.
Cancer Science|April 2, 2011
Essential role of the Hedgehog signaling pathway in human glioma-initiating cellsTatsuya Takezaki, Takuichiro Hide, Hiromi Takanaga, et al.
Cancer Science|April 2, 2011
Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissuesKei Shimizu-Kohno, Yorifumi Satou, Fumiko Arakawa, et al.
Pageof 711

Showing results (91-100 of 7,104) with videos related to

Sort By:
Pageof 711
Cancer Science|November 20, 2010
Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cellsYusuke Tomita, Michiko Harao, Satoru Senju, et al.
Cancer Science|March 16, 2011
A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathwayMorihiko Sagawa, Takatsune Shimizu, Naoshi Fukushima, et al.
Cancer Science|March 16, 2011
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancerSatoshi Matsusaka, Mitsukuni Suenaga, Yuji Mishima, et al.
Cancer Science|March 16, 2011
Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapyYasufumi Sato
Cancer Science|March 5, 2011
Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patientsHidekazu Kameshima, Tetsuhiro Tsuruma, Toshihiko Torigoe, et al.
Cancer Science|March 5, 2011
Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancerMakoto Osanai, Gang-Hong Lee
Cancer Science|March 30, 2011
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppressionYong-Mei Yang, A-Lei Feng, Cheng-Jun Zhou, et al.
Cancer Science|March 30, 2011
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivoShu Tian, Haitian Quan, Chengying Xie, et al.
Cancer Science|April 2, 2011
Essential role of the Hedgehog signaling pathway in human glioma-initiating cellsTatsuya Takezaki, Takuichiro Hide, Hiromi Takanaga, et al.
Cancer Science|April 2, 2011
Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissuesKei Shimizu-Kohno, Yorifumi Satou, Fumiko Arakawa, et al.
Pageof 711